Skip to content
The Nexus
DossierENTITY

Eric Topol

Coverage of Eric Topol in the Nexus archive.

Earliest in view: Apr 23 · 09:30 UTCMost recent: Jun 16 · 07:00 UTC
Co-mentioned in this coverage
Recent coverage
  • SCIENCEJun 16 · 07:00 UTCSCIENTIFIC AMERICAN
    Eric Topol

    Eric Topol, a famed cardiologist, discusses how AI has transformed biomedical science. The article highlights the impact of artificial intelligence on advancing the field.

  • HEALTHMay 16 · 11:00 UTCSTAT NEWS
    Opinion: The cloudy truth about ‘blue zones’

    The concept of 'blue zones' refers to communities where residents live longer than average, influencing today's longevity movement. The science behind blue zones has been explored over twenty-five years. The idea has become mainstream, especially with peptides and biohackers.

  • HEALTHMay 1 · 13:59 UTCNPR NEWS
    The expert on 'super aging' breaks down the science — and grift — in anti-aging

    Physician Eric Topol discusses the science and myths of anti-aging, focusing on factors like peptides, protein, sleep hygiene, and vaccines. He highlights what actually contributes to healthy aging and critiques misleading claims in the longevity space.

  • HEALTHApr 23 · 09:30 UTCAXIOS
    RFK Jr.'s peptide push could become next wellness boom

    RFK Jr. advocates for loosening federal restrictions on peptides, potentially boosting telehealth companies, compounding pharmacies, and longevity clinics. The FDA will review peptide regulations in July, while experts debate their efficacy and safety, with market projections reaching $180 billion in five years.

Eric Topol · Dossier · The Nexus